baber/WOPTO huggingface dataset:
Patent NZ-531440-A (NZ)
Title: Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as PPAR activators
Inventor: GLOMBIK HEINER
IPC: A61P19/10
Filed: 2002-08-17
Abstract: Diaryl cycloalkyl derivatives of formula (I), their physiologically compatible salts and physiologically functional derivatives, and a method for producing these derivatives is disclosed, wherein the variables are as defined in the specification. These compounds have lipid and/or triglyceride reducing properties and are suitable for treating lipid metabolic disorders, type II diabetes and syndrome X.
Patent NZ-535538-A (NZ)
Title: Marine time-lapse seismic surveying
Inventor: CALVERT RODNEY WILLIAM
IPC: G01V1/36
Filed: 2003-04-16
Abstract: A method of surveying the subsurface 5 using a seismic source 13 and at least one seismic receiver 11, 12 is disclosed. The source and receivers are placed at predetermined positions and a set of at least two sound waves at different sea states 20a, 20b is emitted, resulting in a set of repeat signals recorded at the receivers. After a period of time the source and receivers are again placed in the predetermined positions and each seismic receiver records a monitor signal in response to a sound wave emitted from the source and the two-way water travel time is measured. A model is generated for the signal that includes the subsurface signal, differences in the subsurface signals due to changes in the subsurface, and the contributions of surface multiple reflections. A set of filter functions is calculated that enable eliminating the surface multiple reflections. For each receiver an estimated difference in the subsurface signal is calculated from the repeat signals, the monitor signal and the filter functions. This difference is a measure of the subsurface change in the period between the repeat signals and the recording of the monitor signal.
Patent NZ-535593-A (NZ)
Title: Oxygen barrier laminate with paperboard substrate, polyamide layer and two non-contacting oxygen barrier layers, typically both EVOH layers
Inventor: REIGHARD TRICIA SUSAN
IPC: B32B27/10
Filed: 2003-03-17
Abstract: A non-foil barrier laminate structure (5) is provided that results in an improvement in shelf life performance of packaged food products over existing non-foil barrier laminates. Containers constructed from the barrier laminates of the invention can be hot filled or cold filled and can be stored at either ambient conditions or refrigerated conditions. The laminate structures have a polyamide layer (14) for mechanical strength and thermal resistance; a first EVOH layer (16) as a barrier to oxygen ingress applied in direct contact with the polyamide layer and a second barrier layer of EVOH, nylon or the like (24) positioned closer to the product's contact surface (28) that may act as a barrier to oxygen, water vapour, flavour/aroma, or a combination, which is not in contact with the first oxygen barrier layer of EVOH, and layers of polyolefin (12, 20) on both the matte side (interior) and the gloss side (exterior) of the laminate for heat sealing.
Patent NZ-539390-A (NZ)
Title: Azaindole derivatives as inhibitors of p38 kinase
Inventor: DUGAR SUNDEEP
IPC: A61K31/56
Filed: 2003-10-09
Abstract: Disclosed is a compound of formula 1 related to azaindole coupled through piperazine or piperidine moieties to an aryl group, wherein its substituents are as defined in the specification. These compounds are useful in treating various disorders associated with enhanced activity of kinase p38 e.g. proinflammation response.
Patent NZ-539664-A (NZ)
Title: Bismuth oxide superconducting wire rod and process for producing the same
Inventor: AYAI NAOKI
IPC: H01L39/24
Filed: 2004-06-14
Abstract: A method of manufacturing a bismuth based oxide superconducting wire is disclosed, which comprises the steps of preparing a raw material powder and subjecting the raw material powder to plastic working and heat treatment; wherein the raw material powder contains superconducting phases (particularly orthorhombic superconducting phases) comprising Bi, Pb, Sr, Ca, Cu, and O in a composition ratio of approximately 2:2:1:2 (Bi+Pb):Sr:Ca:Cu and non-superconducting phases containing Pb; wherein the composition ratio (Bi+Pb):Sr:Ca:Cu of the raw material powder is approximately 2:2:2:3; and wherein the ratio of the non-superconducting phases to the superconducting phases is 5 wt% or less, so that not only is the orientation of Bi-2223 crystal improved but also the aggregation of non-superconducting phase is inhibited to thereby realise high critical current density.
Patent NZ-541875-A (NZ)
Title: Intranasal formulation of rotigotine and cyclodextrin
Inventor: KRAMER ROBERT
IPC: A61P25/16
Filed: 2004-12-22
Abstract: Disclosed is a liquid intranasal pharmaceutical formulation comprising a pharmaceutically acceptable acid addition salt of rotigotine and alpha-cyclodextrin, preferably in the form of a buffered aqueous solution having a viscosity of 0.5 - 1.5 mm2/s.
Patent NZ-546299-A (NZ)
Title: Immunogenic composition and method of developing a vaccine based on portions of the HIV matrix protein
Inventor: KARP NELSON M
IPC: C07K14/16
Filed: 2004-10-25
Abstract: Provided is a composition including specified protein and DNA sequences of HIV-1 MA polypeptide myrisate binding site and a pharmaceutically acceptable support capable of selectively eliciting a substantially Th-1 immune response to HIV-1. Further provided is the use of the composition for the manufacture of a medicament for treating HIV and use of the composition to treat animals.
Patent NZ-548009-A (NZ)
Title: Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation
Inventor: TREICHLER HANS-JORG
IPC: A61K31/70
Filed: 2004-12-21
Abstract: The disclosure relates to a cobalamin derivative of formula (I) wherein the substituents are defined in the specification. Also disclosed is a composition comprising the cobalamin derivative and the use of said derivative in the manufacture of a pharmaceutical composition for diagnosis of or treatment of a mammal suffering from a neoplastic disease or microorganism infection.
Patent NZ-548373-A (NZ)
Title: A control system for aligning a tool and an object
Inventor: DAVIES KEVIN STEPHEN
IPC: B23Q17/22
Filed: 2004-12-10
Abstract: A control system for a machine having a tool arranged to move through a known path of movement is provided. The control system includes a detector to find the location of objects in or adjacent to the path of the tool, and a processor/ controller to determine the distance between the objects and a leading edge of the tool, where the control system includes a first mode of operation in which the processor/ controller controls movement of the tool. This ensures that if it is determined that the distance between the objects and the leading edge is not within minimum and maximum values, the tool is moved to bring said distance between the minimum and maximum values.
Patent NZ-550388-A (NZ)
Title: Recessed back flashing
Inventor: KENNEDY ANTHONY DAVID
Filed: 2006-10-09
Abstract: A backing flashing in a single length of material folded with four lengthwise folds running parallel to the longitudinal edges giving five external faces A to E. Progressing around the perimeter of the section, B is separated from A by a 45 degree bend in a first direction, C is folded from B at 165 degrees in the opposite second direction, D is folded from C at 165 degrees in the second direction, and E is folded from D in the first direction.
Patent NZ-554124-A (NZ)
Title: Adaptive milking system
Inventor: TUCKER GEORGE H
Filed: 2007-03-26
Abstract: A milking method for cows and similar animals using teat-cups attached to the teats of the animal for milk flow to a claw and collection container, involves sensing the milk flow for the individual animal and detaching the teat-cups from the teats in response to a detach threshold being reached when the milk flow falls below the detach threshold. The detach threshold itself is adaptively varied for each individual animal in response to the measurement of the milk flow for that animal. Other milking parameters, such as let-down delay, may also be adaptively varied in response to the measured milk flow for the individual animal.
Patent NZ-555336-A (NZ)
Title: Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound
Inventor: MACHARLA JAGANNATH
IPC: A61P17/10
Filed: 2005-11-08
Abstract: Disclosed is a topical pharmaceutical composition and a process of preparing said composition, comprising (a) a, therapeutically effective amount of adapalene or a pharmaceutically acceptable salt or ester thereof; (b) clindamycin or a pharmaceutically acceptable salt or ester thereof; and (c) a hydrophilic matrix comprising a carbomer polymer. The carbomer polymer matrix provides a constant and uniform release of both active ingredients.
Patent NZ-561323-A (NZ)
Title: Acetic acid production methods incorporating at least one metal salt as a catalyst stabilizer
Inventor: TORRENCE G
IPC: C07C51/12
Filed: 2006-02-10
Abstract: A process for the production of acetic acid, by a catalytic carbonylation reaction, comprising reacting methanol in a reaction mixture, in the presence of carbon monoxide and a rhodium-based catalyst system comprising: (i) rhodium in a concentration of at least 300 ppm; (ii) a halogen promoter selected from hydrogen iodide and an organic iodide; (iii) an iodide salt co-promoter in the form of a soluble salt of alkali metal or alkaline earth metal or quaternary ammonium or phosphonium salt at a concentration that generates an iodide ion concentration of greater than 3 wt.% of the reaction mixture; and (iv) a metal salt stabilizer selected from the group consisting of ruthenium salts, tin salts, and mixtures thereof; wherein the reaction mixture comprises from 0.1 wt.% to 14 wt.% water, and wherein the ruthenium salts, tin salts, and mixtures thereof are present in the reaction mixture in a molar ratio of combined ruthenium and tin to rhodium of from 0.1:1 to 20:1.
Patent NZ-561814-A (NZ)
Title: Overmolded containers and methods of manufacture and use thereof
Inventor: SHI YU
IPC: B29B11/08
Filed: 2006-02-17
Abstract: A method for making an over moulded container comprises the steps of providing a container preform 12 which comprises a thermoplastic polymer, overmolding an elastomeric material 14 over at least a portion of the perform 12 to form an overmolded perform 16, and blow-molding the overmolded perform 16 using a stretch blow mould process where the overmolded material is conformingly stretched with the preform to form an overmolded container 20. The container will have enhanced visual and tactile characteristics.
Patent NZ-563606-A (NZ)
Title: An expanded food product comprising hominy
Inventor: HARDACRE ALLAN KEITH
IPC: A23L7/10
Filed: 2007-11-21
Abstract: Provided is an expanded food product comprising about 49-94.3% w/w hominy and about 5-60% w/w dairy protein isolate(s). The dairy protein isolates can be selected from lactic casein, MPC 85, MPC70, WPC392, WP1894, Alatel 825 or a mixture thereof and can be included in breakfast cereals and snack food.
Patent NZ-570887-A (NZ)
Title: Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
Inventor: KUNG HANK F
IPC: A61K51/04
Filed: 2007-03-26
Abstract: Disclosed are styrylpyridine compounds of formula (I), wherein R2 is an ether moiety of formula (i) or formula (ii), and the rest of the substituents are disclosed within the specification. Also disclosed is the use of the compounds of formula (I), which is radiolabeled, in the manufacture of a diagnostic composition for use in a method of imaging amyloid deposits in a mammal.
Patent NZ-576624-A (NZ)
Title: A method for damping tower oscillations, an active stall controlled wind turbine and use hereof
Inventor: NIELSEN THOMAS STEINICHE BJERTRUP
IPC: F03D7/02
Filed: 2007-10-04
Abstract: Disclosed is a method for damping tower oscillations in a tower of an active stall controlled wind turbine. The said method comprises the steps of: a. operating two or more blades of said wind turbine in a stall condition; b. detecting if said tower oscillates beyond a predefined level; and c. establishing different stall conditions between at least two of said blades. The different stall conditions of the method are established by offsetting a pitch angle of at least a first blade in relation to a pitch angle of one further blade.
Patent NZ-579997-A (NZ)
Title: PROCESS FOR PREPARATION OF N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
Inventor: RAO DHARMARAJ RAMCHANDRA
IPC: C07D239/94
Filed: 2008-04-03
Abstract: Disclosed is a process for the preparation of a salt of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine (Erlotinib) comprising: reacting a 4-halo-6,7-bis(2-methoxyethoxy)quinazoline with 3-aminophenyl acetylene (or an acid salt thereof under acidic conditions) in a solvent, the solvent being selected from the group consisting water, dimethyl carbonate, special denatured spirit (SPDS), acetonitrile, acetone, ethyl acetate, isopropyl alcohol and mixtures thereof. The process optionally further comprises converting the acid salt of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine to N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine. The process can be carried out under ambient conditions.
Patent NZ-585601-A (NZ)
Title: Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp.
Inventor: FOX BRYAN P
IPC: C07K14/36
Filed: 2008-01-29
Abstract: Disclosed is a Bacillus sp. host cell comprising: a recombinant nucleic acid encoding a fusion protein comprising: a) a signal sequence; and b) a Streptomyces Subtilisin Inhibitor (SSI) protein; wherein said host cell secretes said SSI protein from said cell wherein said host cell has inactivated aprE, nprE, epr, ispA, bpr, vpr, wprA, mpr-ybjF and nprB genes.
Patent NZ-585893-A (NZ)
Title: Soy compositions having improved organoleptic properties and methods of generation
Inventor: BRINGE NEAL A
IPC: A23L11/00
Filed: 2005-07-08
Abstract: Disclosed is a method of obtaining a soybean variety producing soybeans with decreased odour producing properties comprising measuring the level of at least one compound selected from the group consisting of 2,4 decadienal, hexanol, hexanal, 1-octen-3-ol, and any combination thereof in one or more soybeans from first and second soybean varieties and selecting the variety producing seeds with lower levels of said compound.
Patent NZ-590882-A (NZ)
Title: Method for retarding the setting of the surface of a concrete using ester-based concrete surface retarders
Inventor: VINCENT DANY
IPC: C04B41/53
Filed: 2009-08-19
Abstract: Disclosed is a method for retarding the surface of a concrete, mortar, or other cementitious composition, comprising spray-applying onto a surface of a hydratable concrete or mortar or other cementitious material so as to retard the curing thereof or otherwise onto a surface of a mold and thereafter placing a hydratable concrete or mortar or other cementitious material onto the sprayed mold surface, a liquid-spray-applied surface-retarder composition comprising at least one oil/solvent-soluble or oil dispersible alkyl-ester compound contained in the form of particles or as a discontinuous liquid phase distributed within a continuous non-aqueous carrier phase which is spray-applied in liquid form, said alkyl ester compound being selected from the group of an alkyl ester of citric acid, an alkyl ester of tartaric acid, an alkyl ester of malic acid, an alkyl ester of gallic acid, an alkyl ester of glycolic acid, an alkyl ester of gluconic acid, an alkyl ester of lactic acid, an alkyl ester of mandelic acid, an alkyl ester of salicylic acid, or an alkyl ester of 4-hydroxybutanoic acid, and said continuous non-aqueous liquid spray-applied carrier phase comprising a petroleum-based solvent, a vegetable oil, an animal oil, a mineral oil, or mixtures or derivative of the foregoing continuous non-aqueous carrier phases.
Patent NZ-593818-A (NZ)
Title: Polymorphic form of 5-chloro-n-{ [(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl} thiophene-2-carboxamide
Inventor: WEERATUNGA GAMINI
IPC: A61K31/5377
Filed: 2009-12-31
Abstract: 593818 Disclosed is a polymorph of rivaroxaban (5-Chloro-N-{ [(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxa-zolidin-5-yl]-methyl} thiophene-2-carboxamide) which is shown in formula (I). The polymorph is characterised by an x-ray powder diffraction (XRPD) peak at 39.12 2 degrees theta and a differential scanning calorimetry (DSC) thermogram (scan rate 10 deg.C/minute) exhibiting a peak endotherm at an onset temperature of about 166°C and a peak maximum at about 183°C.
Patent NZ-595443-A (NZ)
Title: Control of gene expression in plants using a perennial ryegrass (lolium perenne l.) derived promoter
Inventor: PUTHIGAE SATHISH
IPC: C12N15/113
Filed: 2010-03-26
Abstract: Discloses an isolated promoter polynucleotide that comprises: a) the sequence of SEQ NO: 1 or 7; b) a sequence with at least 70% identity to the sequence of SEQ NO: 1 or 7; c) at least 50 contiguous nucleotides of the sequence of SEQ ID NO: 1 or 7; d) a sequence with at least 70% identity to the sequence of c); or e) the complement of anyone of a) to e) where the promoter polynucleotide is capable of controlling transcription of an operably linked polynucleotide in a plant. Also discloses a method for modifying expression in a plant cell or plant; the method comprising transforming the plant cell with the polynucleotide generated by steps (a) to (e) as disclosed. Also disclosed are genetically modified plants, seeds or tissues, transformed by the method as disclosed. SEQ NO: 1 or 7 are derived from ryegrass (Lolium perenne cv. Bronsyn) promoter polynucleotides.
Patent NZ-598097-A (NZ)
Title: Solid inorganic composition, method for preparing same, and use thereof for reducing dioxins and heavy metals in flue gases
Inventor: LAUDET ALAIN
IPC: B01D53/64
Filed: 2010-07-13
Abstract: Disclosed herein is a composition for reducing heavy metals and dioxins in flue gases comprising a solid sorption material which is a mineral compound selected from phyllosilicates of the "palygorskite-sepiolite" group according to the Dana classification, said mineral compound being doped with one or more halide salts and retaining the initial crystalline structure, said halide salt being present in an amount on a dry basis ranging from 0.5 % to 20% by weight on the basis of the weight of the composition.
Patent NZ-598300-A (NZ)
Title: (thio)morpholine derivatives as s1p modulators
Inventor: COOLEN HEIN K
IPC: A61K31/5377
Filed: 2010-08-27
Abstract: The present disclosure relates to (thio)morpholine derivatives of the formula (I), wherein R1 is selected from cyano, (2-4C)alkynyl, (1-4C)alkyl, (3-6C)cycloalkyl, (4-6C)cycloalkenyl, (6-8C)bicycloalkyl, (8-10C)bicyclic group, each optionally substituted with (1-4C)alkyl, phenyl, biphenyl, naphthyl, each optionally substituted with one or more substituents independently selected from halogen, (1-4C)alkyloptionally substituted with one or more fluoro atoms, (2-4C)alkynyl, (1-4C)alkoxy optionally substituted with one or more fluoro atoms,amino, di(1-4C)alkylamino, -SO2-(1-4C)alkyl, -CO-(1-4C)alkyl, -CO-O-(1-4C)alkyl, -NH-CO-(1-4C)alkyl and (3-6C)cycloalkyl, phenyl substituted with phenoxy, benzyl, benzyloxy, phenylethyl or monocyclic heterocycle, each optionally substituted with (1-4C)alkyl, monocyclic heterocycle optionally substituted with halogen, (1-4C)alkyl or with phenyl optionally substituted with (1-4C)alkyl, and bicyclic heterocycle optionally substituted with (1-4C)alkyl; A is selected from -CO-O-, -O-CO-, -NH-CO-, -CO-NH, -C=C-, -CCH3-O- and the linking group -Y-(CH2)n-X- wherein Y is attached to R1 and selected from a bond, -O-, -S-, -SO-, -SO2-, -CH2-O-, -CO-, -O-CO-, -CO-O-, -CO-NH-, -NH-CO-, -C=C-and -C?C-; n is an integer from 1 to 10; and X is attached to the phenylene / pyridyl group and selected from a bond, -O-, -S-, -SO-, -SO2 -, -NH, -CO-, -C=C-and -C?C-; ring structure B optionally contains one nitrogen atom; R2 is H, (1-4C)alkyl optionally substituted with one or more fluoro atoms, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, or halogen; and R3 is (1-4C)alkylene-R5 wherein the alkylene group may be substituted with (CH2)2 to form a cyclopropyl moiety or one or two halogen atoms, or R3 is is (3-6C)cycloalkylene-R5 or -CO-CH2-R5, wherein R5 is -OH, -PO3H2, -OPO3H2, -COOH, -COO(1-4C)alkyl or tetrazol-5-yl; R4 is H or (1-4C)alkyl; R6 is one or more substituents independently selected from H, (1-4C)alkyl or oxo; W is -O-, -S-, -SO- or -SO2-; or a pharmaceutically acceptable salt, a solvate or hydrate thereof; with the proviso that the derivative of formula (I) is not 2-(4-ethylphenyl)-4-morpholinoethanol or 4-[4-(2-hydroxyethyl)-2-morpholinyl]benzeneacetonitrile or a pharmaceutically acceptable salt, a solvate or hydrate thereof. The compounds of the invention have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of S1P receptor mediated diseases and conditions.
Patent NZ-600629-A (NZ)
Title: Vaccinia virus mutants containing the major genomic deletions of mva
Inventor: MEISINGER-HENSCHEL CHRISTINE
IPC: C12N7/02
Filed: 2011-01-28
Abstract: The present disclosure provides methods of producing modified vaccinia virus (VACV) genomes and related vectors. The method consists essentially in deleting the vaccinia genomic regions corresponding to those that are present in the Chorioallantois Vaccinia virus but absent in the Modified Vaccinia Ankara virus. The resulting viruses, vectors and host cells are also disclosed. Moreover, a method for determining the effect of a mutation on a vaccinia virus, using one of the modified vaccinia viruses of the invention, is also disclosed.
Patent NZ-606548-A (NZ)
Title: Dry powder formulation comprising a phosphodiesterase inhibitor
Inventor: SCHIARETTI FRANCESCA
IPC: A61P11/06
Filed: 2011-07-27
Abstract: Disclosed herein is a pharmaceutical formulation in the form of an inhalable dry powder, comprising micronized particles of a compound of general formula (I) as (-) enantiomer, wherein the variables are as defined in the specification; and coarse carrier particles made of a physiologically acceptable pharmacologically-inert material having a mass diameter of 150 to 400 micron with a fissure index of at least 1.25; wherein said compound is administered at a therapeutically effective single dose comprised between 300 micrograms and 1000 micrograms; and wherein the preferred compound of formula (I) is (-)-3-Cyclopropylmethoxy-4-methanesulfonylamino-benzoic acid 1-(3-cyclopropylmethoxy-4-difluoromethoxy-phenyl)-2-(3,5-dichloro-1-oxy-pyridin-4-yl)-ethyl ester. The formulations of the invention are intended for use in the prevention and/or treatment of a respiratory disease such as asthma or COPD.
Patent NZ-707005-A (NZ)
Title: Thermomechanical processing of high strength non-magnetic corrosion resistant material
Inventor: FORBES JONES ROBIN M
IPC: E21B17/10
Filed: 2014-02-17
Abstract: A method of processing a non-magnetic alloy workpiece comprises heating the workpiece to a warm working temperature, open die press forging the workpiece to impart a desired strain in a central region of the workpiece, and radial forging the workpiece to impart a desired strain in a surface region of the workpiece. In a non-limiting embodiment, after the steps of open die press forging and radial forging, the strain imparted in the surface region is substantially equivalent to the strain imparted in the central region. In another non-limiting embodiment, the strain imparted in the central and surface regions are in a range from 0.3 inch/inch to 1 inch/inch, and there exists no more than a 0.5 inch/inch difference in strain of the central region compared with the strain of the surface region of the workpiece. An alloy forging processed according to methods described herein also is disclosed.